At a time when the TGA is scrutinising the industry like never before, simply saying your product is produced to GMP guidelines is not enough. Novachem cannabis products manager Andrew Heath explains.
Good Manufacturing Practice (GMP) is an absolute requirement for all medicines. Australian medicine manufacturers, including those making cannabis products, need to comply with GMP guidelines to have them accepted for patient end use in this country.
The Therapeutic Goods Administration’s upcoming changes in GMP expectations for imported medicinal cannabis products have shone a spotlight on the different levels of GMP applied to products in local and overseas markets, highlighting a need to know more about quality provenance and processes.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
